Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-37,672
Closed -$1.93M 548
2024
Q4
$1.93M Buy
37,672
+18,393
+95% +$953K 0.06% 289
2024
Q3
$857K Buy
+19,279
New +$843K 0.04% 289
2023
Q2
Sell
-149,000
Closed -$4.59M 188
2023
Q1
$4.59M Buy
+149,000
New +$5.67M 0.55% 63
2019
Q1
Sell
-66,011
Closed -$2.11M 60
2018
Q4
$2.11M Buy
+66,011
New +$2.49M 0.32% 55

Other funds holding SNV

Crestline Management's SNV Position: Q1 2025 in Review

Crestline Management sold out of Synovus (SNV) in Q1 2025, closing a stake of 37,672 shares — an estimated $1.93M sold.

Crestline Management first reported a position in SNV in Q4 2018 and held it in 4 quarters. The position peaked at $4.59M in Q1 2023. 478 funds tracked by Wall St. Rank hold SNV as of Q1 2025.

  • Crestline Management reported no remaining Synovus position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 37,672 Synovus shares in Q1 2025, an estimated $1.93M.
  • Crestline Management first reported a position in Synovus in Q4 2018 and held it in 4 quarters.
  • Crestline Management's Synovus position peaked at $4.59M in Q1 2023.
  • 478 funds tracked by Wall St. Rank held Synovus as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.